| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism GPR75 inhibitors(G protein-coupled receptor 75 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Phase 2 | Canada  | 30 Nov 2021 | |
| Neoplasms | Phase 2 | Canada  | 30 Nov 2021 | |
| Obesity | Preclinical | Canada  | 01 Feb 2025 | 





